Proteomic identification of proteins suggestive of immune-mediated response or neuronal degeneration in serum of achalasia patients

Gut and Liver

Volumn 7, Issue 4, 2013, Pages 411-416

  Im, Seon Kyo ^a   Yeo, Mari ^a   Lee, Kwang Jae ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Esophageal achalasia; Immune response; Neuronal degeneration; Proteomics

Indexed keywords

ALPHA 2 MACROGLOBULIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4B; CYCLIN DEPENDENT KINASE 5; PREALBUMIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS ACHALASIA; HUMAN; IMMUNE RESPONSE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NERVE CELL DEGENERATION; PROTEOMICS; UPREGULATION;

EID: 84880304707     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2013.7.4.411     Document Type: Article

References (25)

1. Katz PO, Richter JE, Cowan R, Castell DO. Apparent complete lower esophageal sphincter relaxation in achalasia. Gastroenterology 1986;90:978-983.
2. Park W, Vaezi MF. Etiology and pathogenesis of achalasia: the current understanding. Am J Gastroenterol 2005;100:1404-1414.
3. Wilkins MR, Pasquali C, Appel RD, et al. From proteins to proteomes: large scale protein identification by two-dimensional electrophoresis and amino acid analysis. Biotechnology (NY) 1996;14:61-65.
4. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001;69:89-95.
5. Sultana R, Boyd-Kimball D, Poon HF, et al. Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD. Neurobiol Aging 2006;27:1564-1576.
6. Goldblum JR, Whyte RI, Orringer MB, Appelman HD. Achalasia. A morphologic study of 42 resected specimens. Am J Surg Pathol 1994;18:327-337.
7. Goldblum JR, Rice TW, Richter JE. Histopathologic features in esophagomyotomy specimens from patients with achalasia. Gastroenterology 1996;111:648-654.
8. Frieling T, Berges W, Borchard F, Lübke HJ, Enck P, Wienbeck M. Family occurrence of achalasia and diffuse spasm of the oesophagus. Gut 1988;29:1595-1602.
9. Robertson CS, Martin BA, Atkinson M. Varicella-zoster virus DNA in the oesophageal myenteric plexus in achalasia. Gut 1993;34:299-302.
10. Parrilla P, Aguayo JL, Martinez de Haro L, Ortiz A, Martinez DA, Morales G. Reversible achalasia-like motor pattern of esophageal body secondary to postoperative stricture of gastroesophageal junction. Dig Dis Sci 1992;37:1781-1784.
11. Qualman SJ, Haupt HM, Yang P, Hamilton SR. Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease. Gastroenterology 1984;87:848-856.
12. Murphy MS, Gardner-Medwin D, Eastham EJ. Achalasia of the cardia associated with hereditary cerebellar ataxia. Am J Gastroenterol 1989;84:1329-1330.
13. Tumani H, Lehmensiek V, Lehnert S, Otto M, Brettschneider J. 2D DIGE of the cerebrospinal fluid proteome in neurological diseases. Expert Rev Proteomics 2010;7:29-38.
14. Ando Y, Ueda M. Novel methods for detecting amyloidogenic proteins in transthyretin related amyloidosis. Front Biosci 2008;13:5548-5558.
15. Hou X, Aguilar MI, Small DH. Transthyretin and familial amyloidotic polyneuropathy. Recent progress in understanding the molecular mechanism of neurodegeneration. FEBS J 2007;274:1637-1650.
16. Walport MJ. Complement. First of two parts. N Engl J Med 2001;344:1058-1066.
17. Morgan BP, Gasque P. Expression of complement in the brain: role in health and disease. Immunol Today 1996;17:461-466.
18. Coleman RM, Lombard MF, Sicard RE, Rencricca NJ. Fundamental immunology. Dubuque: Brown Publishers, 1989.
19. Storch WB, Eckardt VF, Junginger T. Complement components and terminal complement complex in oesophageal smooth muscle of patients with achalasia. Cell Mol Biol (Noisy-le-grand) 2002;48:247-252.
20. Kesavapany S, Li BS, Amin N, Zheng YL, Grant P, Pant HC. Neuronal cyclin-dependent kinase 5: role in nervous system function and its specific inhibition by the Cdk5 inhibitory peptide. Biochim Biophys Acta 2004;1697:143-153.
21. Maccioni RB, Otth C, Concha II, Muñoz JP. The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology. Eur J Biochem 2001;268:1518-1527.
22. Honjyo Y, Kawamoto Y, Nakamura S, Nakano S, Akiguchi I. Immunohistochemical localization of CDK5 activator p39 in the rat brain. Neuroreport 1999;10:3375-3379.
23. Sottrup-Jensen L, Sand O, Kristensen L, Fey GH. The alpha-macroglobulin bait region. Sequence diversity and localization of cleavage sites for proteinases in five mammalian alpha-macroglobulins. J Biol Chem 1989;264:15781-15789.
24. Mocchegiani E, Costarelli L, Giacconi R, Cipriano C, Muti E, Malavolta M. Zinc-binding proteins (metallothionein and alpha-2 macroglobulin) and immunosenescence. Exp Gerontol 2006;41:1094-1107.
25. Kovacs DM. alpha2-macroglobulin in late-onset Alzheimer's disease. Exp Gerontol 2000;35:473-479.